Molina Healthcare, Inc. (MOH)
NYSE: MOH · Real-Time Price · USD
294.01
-1.33 (-0.45%)
At close: Jun 20, 2025, 4:00 PM
294.10
+0.09 (0.03%)
After-hours: Jun 20, 2025, 7:11 PM EDT
Molina Healthcare Stock Forecast
Stock Price Forecast
The 17 analysts that cover Molina Healthcare stock have a consensus rating of "Buy" and an average price target of $363.81, which forecasts a 23.74% increase in the stock price over the next year. The lowest target is $297 and the highest is $414.
Price Target: $363.81 (+23.74%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Molina Healthcare stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 3 | 3 | 5 | 5 | 5 | 6 |
| Hold | 6 | 8 | 7 | 9 | 9 | 9 |
| Sell | 1 | 1 | 1 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 12 | 14 | 15 | 16 | 16 | 17 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Hold Maintains $351 → $347 | Hold | Maintains | $351 → $347 | +18.02% | Jun 9, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Initiates $364 | Buy | Initiates | $364 | +23.81% | Jun 9, 2025 |
| Barclays | Barclays | Hold Maintains $362 → $351 | Hold | Maintains | $362 → $351 | +19.38% | Jun 2, 2025 |
| Barclays | Barclays | Hold Maintains $339 → $362 | Hold | Maintains | $339 → $362 | +23.13% | Apr 25, 2025 |
| Bernstein | Bernstein | Buy Initiates $414 | Buy | Initiates | $414 | +40.81% | Apr 22, 2025 |
Financial Forecast
Revenue This Year
44.65B
from 39.16B
Increased by 14.02%
Revenue Next Year
48.16B
from 44.65B
Increased by 7.86%
EPS This Year
24.73
from 20.42
Increased by 21.09%
EPS Next Year
28.59
from 24.73
Increased by 15.64%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 47.1B | 51.5B | 54.9B | ||
| Avg | 44.7B | 48.2B | 51.3B | ||
| Low | 42.7B | 44.9B | 48.0B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 20.2% | 15.3% | 14.0% | ||
| Avg | 14.0% | 7.9% | 6.6% | ||
| Low | 9.2% | 0.5% | -0.3% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 26.00 | 32.55 | 37.38 | ||
| Avg | 24.73 | 28.59 | 33.08 | ||
| Low | 23.22 | 27.12 | 30.08 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 27.3% | 31.6% | 30.7% | ||
| Avg | 21.1% | 15.6% | 15.7% | ||
| Low | 13.7% | 9.7% | 5.2% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.